Toenail nicotine levels as predictors of coronary heart disease among women

American Journal of Epidemiology

Volumn 167, Issue 11, 2008, Pages 1342-1348

  Al Delaimy, Wael K ^a,d   Stampfer, Meir J ^b,c   Manson, Joann E ^b,c   Willett, Walter C ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

Biological markers; Cohort studies; Coronary disease; Nails; Nicotine; Tobacco

Indexed keywords

NICOTINE;

BIOMARKER; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; HEALTH RISK; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; TOBACCO; WOMENS HEALTH;

ADULT; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DOSE RESPONSE; FEMALE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAIL; PASSIVE SMOKING; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; NAILS; NICOTINE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STATISTICS, NONPARAMETRIC;

NICOTIANA TABACUM;

EID: 44449140062     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn061     Document Type: Article

References (32)

1. Office of the Surgeon General. Reducing the health consequences of smoking: 25 years of progress: a report of the Surgeon General. Rockville, MD: Office on Smoking and Health, Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, 1989. (DHHS publication no. (CDC) 89-8411).
2. The health consequences of smoking: a report of the Surgeon General. Washington, DC: Office on Smoking and Health, Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, 2004.
3. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta, GA: Office on Smoking and Health, Center for Chronic Disease Prevention and Health Promotion, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, 2006:85-92.
4. He J, Vupputuri S, Allen K, et al. Passive smoking and the risk of coronary heart disease - a meta-analysis of epidemiologic studies. N Engl J Med 1999;340:920-6.
5. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. The Pooling Project Research Group. J Chronic Dis 1978;31:201-306.
6. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology 1999;145:1-20.
7. Patterson F, Benowitz N, Shields P, et al. Individual differences in nicotine intake per cigarette. Cancer Epidemiol Biomarkers Prev 2003;12:468-71.
8. Prescott E, Scharling H, Osler M, et al. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in the Copenhagen City Heart Study. J Epidemiol Community Health 2002;56:702-6.
9. Woodward M, Moohan M, Tunstall-Pedoe H. Self-reported smoking, cigarette yields and inhalation biochemistry related to the incidence of coronary heart disease: results from the Scottish Heart Health Study. J Epidemiol Biostat 1999;4:285-95.
10. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43:1731-7.
11. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005;111:2684-98.
12. Hanna ST. Nicotine effect on cardiovascular system and ion channels. J Cardiovasc Pharmacol 2006;47:348-58.
13. Secker-Walker RH, Vacek PM, Flynn BS, et al. Exhaled carbon monoxide and urinary cotinine as measures of smoking in pregnancy. Addict Behav 1997;22:671-84.
14. Tunstall-Pedoe H, Brown CA, Woodward M, et al. Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish Heart Health Study. J Epidemiol Community Health 1995;49:139-43.
15. Rubinstein M, Thompson PJ, Benowitz N, et al. Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine Tob Res 2007;9:129-35.
16. Peterson EL, Johnson CC, Ownby DR. Use of urinary cotinine and questionnaires in the evaluation of infant exposure to tobacco smoke in epidemiologic studies. J Clin Epidemiol 1997;50:917-23.
17. O'Connor RJ, Giovino GA, Kozlowski LT, et al. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol 2006;164:750-9.
18. Jenkins R, Counts R. Personal exposure to environmental tobacco smoke: salivary cotinine, airborne nicotine, and nonsmoker misclassification. J Expo Anal Environ Epidemiol 1999;9:352-63.
19. Riedel K, Scherer G, Engl J, et al. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol 2006;30:187-95.
20. Bryant MS, Skipper PL, Tannenbaum SR, et al. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 1987;47:602-8.
21. Hill P, Haley NJ, Wynder EL. Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis 1983;36:439-49.
22. Emerson JA, Hovell MF, Meltzer SB, et al. The accuracy of environmental tobacco smoke exposure measures among asthmatic children. J Clin Epidemiol 1995;48:1251-9.
23. Margolis PA, Keyes LL, Greenberg RA, et al. Urinary cotinine and parent history (questionnaire) as indicators of passive smoking and predictors of lower respiratory illness in infants. Pediatr Pulmonol 1997;23:417-23.
24. Al-Delaimy WK, Mahoney GN, Speizer FE, et al. Toenail nicotine levels as a biomarker of tobacco smoke exposure. Cancer Epidemiol Biomarkers Prev 2002;11:1400-4.
25. Freedberg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's dermatology in general medicine. 4th ed. New York, NY: McGraw-Hill Book Co, 1999.
26. Al-Delaimy WK, Willett WC. Measurement of tobacco smoke exposure: comparison of toenail nicotine biomarkers and self-reports. Cancer Epidemiol Biomarkers Prev (in press).
27. Mahoney GN, Al-Delaimy W. Measurement of nicotine in hair by reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 2001;753:179-87.
28. Al-Delaimy WK, Crane J, Woodward A. Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine? J Epidemiol Community Health 2002;56:66-71.
29. Repace J, Al-Delaimy WK, Bernert JT. Correlating atmospheric and biological markers in studies of secondhand tobacco smoke exposure and dose in children and adults. J Occup Environ Med 2006;48:181-94.
30. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000;343:530-7.
31. Whincup PH, Gilg JA, Emberson JR, et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ 2004;329:200-4.
32. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.